查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1901521

移植诊断市场依产品类型、技术、应用、最终用户、国家及地区划分－全球产业分析、市场规模、市场占有率及2025-2032年预测

Transplant Diagnostics Market by Product Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年移植诊断市场规模为 62.6798 亿美元，从 2025 年到 2032 年将以 7.5% 的复合年增长率成长。

全球移植诊断（TD）市场正经历强劲成长，这主要得益于末期器官疾病盛行率的上升，进而推动了全球器官和干细胞移植手术数量的增加。该市场主要关注人类白血球抗原（HLA）分型、抗体检测和移植后监测，以确保供体与受体的相容性并最大限度地减少移植排斥反应。技术进步，特别是下一代定序（NGS）和供体来源的游离DNA（dd-cfDNA）检测，正在透过提供高解析度的配型和非侵入性排斥监测，改变诊断格局。这些创新方法正在改善患者预后，并扩大诊断平台在医院和专业参考实验室的临床应用范围。先进诊断平台的高昂成本和持续的器官短缺仍然是限制市场发展的关键因素。

移植诊断市场－市场动态

分子检测技术进步

技术进步是推动这一趋势的关键因素，主要体现在从血清学和基于PCR的检测方法转向高解析度定序技术的转变。例如，2023年10月，美国GenDx公司推出了NGS-Turbo，这是一款旨在革新高解析度HLA分型的新一代解决方案。该产品利用牛津奈米孔技术公司的定序平台，提供快速、准确且可扩展的分型结果，显着缩短了周转时间，并增强了移植诊断中的相容性评估。采用下一代定序（NGS）进行HLA分型至关重要，因为它可在等位基因层面上提供无与伦比的分辨率，从而实现更准确的供体-受体匹配，并显着降低移植物抗宿主疾病（GVHD）和排斥反应的风险。此外，利用分子检测方法进行非侵入性监测（例如定量受体血液中的dd-cfDNA）可为同种异体移植损伤提供早期、可靠的生物标记物，从而推动临床管理向个人化医疗策略发展。研发资金的增加和这些尖端检测方法的监管审批的利好，加速了这一趋势。

移植诊断市场細項分析：

全球移植诊断市场按产品类型、技术、应用、最终用户和地区进行细分。

依产品类型，市场分为三大类：试剂及耗材、仪器以及软体及服务。由于移植手术数量庞大，且对专用HLA分型试剂盒、检测抗体和核酸萃取试剂的需求持续存在，因此试剂及耗材类市场份额最大。

根据技术划分，市场可分为两大类：分子检测和非分子检测及其他检测。分子检测，包括基于PCR和测序（NGS、Sanger测序）的方法，因其卓越的准确性和高通量能力（对于解析复杂的HLA等位基因至关重要）而占据市场主导地位。非分子检测包括血清学检测和混合淋巴细胞培养（MLC）检测。

根据应用领域，市场可分为两大类：诊断应用（移植前诊断、移植后监测）、研究应用和其他应用。诊断应用是主导领域，其主要驱动力是强制性的移植前相容性检测。

根据最终用户，市场可分为三大类：医院和移植中心、诊断实验室以及研究和学术机构及其他。诊断实验室（包括独立参考实验室）凭藉其高通量处理能力和复杂分子检测的专业知识，占据了相当大的市场份额。

移植诊断市场—地域洞察

北美占据最大的市场份额，这主要归功于其完善的医疗基础设施、对先进诊断技术的高度认知以及大量的器官移植手术，尤其是肾臟和心臟移植。欧洲紧随其后，这得益于标准化的器官共享计画（如欧洲移植中心）以及对医疗研究的大力公共投入，从而促进了非侵入性监测系统的早期应用。亚太地区预计将成为成长最快的市场，这主要得益于医疗支出的快速增长、慢性病发病率的上升以及政府支持器官捐赠计画的政策不断完善，尤其是在中国和印度等国家。拉丁美洲和中东及非洲地区的成长较为缓慢但稳定，主要受制于医疗体系分散和技术成本高昂，不过政府的策略性投资正在创造市场机会。

移植诊断市场—国家/地区洞察

中国人口基数庞大，近年来器官捐赠体系的监管取得了显着进展，因此有望成为高潜力市场。中国大幅扩大了自愿捐赠器官计划，导致器官移植数量激增，对精准移植诊断的需求也随之飙升。推动这一成长的关键因素包括政府推行医院基础设施现代化、大力投资国内分子诊断研发，以及自动化、高通量HLA分型系统（通常是本地生产或改造的）的日益普及。然而，该市场也面临许多挑战，例如如何统一不同地区医院的检测流程，以及如何解决解读复杂NGS资料所需的高素质专业人员短缺的问题。为了适应监管框架，市场进入策略通常需要与当地企业建立合作关係。

目录

第一章：移植诊断市场概览

  • 研究范围
  • 市场估算年份

第二章：执行概要

  • 市集
  • 竞争洞察

第三章：移植诊断市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章：移植诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章：移植诊断市场：地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：移植诊断市场概况

  • 移植诊断市占率分析，2024 年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章：移植诊断市场：依产品类型划分

  • 概述
    • 细分市场占有率分析：依产品类型
    • 试剂和耗材
    • 仪器
    • 软体与服务
    • 其他的

第八章：移植诊断市场：依技术划分

  • 概述
    • 细分市场占有率分析：依技术划分
    • 分子检测
      • 基于PCR的检测
      • 基于定序的检测方法（NGS、Sanger测序）
    • 非分子检测
      • 血清学检测
      • 混合淋巴球培养（MLC）
    • 其他的

第九章：移植诊断市场：依应用领域划分

  • 概述
    • 细分市场占有率分析：按应用
    • 诊断应用
      • 移植前诊断（HLA分型、交叉配对）
      • 移植后监测（排斥/感染）
    • 研究应用
    • 其他的

第十章：移植诊断市场：依最终用户划分

  • 概述
    • 细分市场占有率分析：按应用
    • 医院及移植中心
    • 诊断实验室（独立参考实验室）
    • 研究与学术机构
    • 其他的

第十一章：移植诊断市场：依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十二章：主要供应商分析：移植诊断产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • CareDx, Inc.
    • Immucor, Inc. (part of Werfen)
    • Illumina, Inc.
    • Qiagen NV
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Omixon Ltd.
    • Eurofins Scientific SE
    • Others

第13章：全面展望

简介目录
Product Code: ANV5901

The Transplant Diagnostics Market size was valued at US$6,267.98 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

The global Transplant Diagnostics (TD) market is experiencing robust growth driven by the rising number of organ and stem cell transplantation procedures worldwide due to the increasing prevalence of end-stage organ diseases. The market primarily focuses on Human Leukocyte Antigen (HLA) typing, antibody detection, and post-transplant monitoring to ensure donor-recipient compatibility and minimize graft rejection. Technological advancements, particularly in Next-Generation Sequencing (NGS) and donor-derived cell-free DNA (dd-cfDNA) testing, are transforming the diagnostic landscape by offering high-resolution matching and non-invasive rejection monitoring. These innovative approaches are improving patient outcomes and expanding the clinical utility of diagnostic platforms across hospitals and specialized reference laboratories. The high cost of advanced diagnostic platforms and a persistent organ shortage remain key constraints.

Transplant Diagnostics Market- Market Dynamics

Technological Advancements in Molecular Assays

Technological progress is the paramount driver, primarily through the shift from serological and PCR-based assays to high-resolution sequencing technologies, for instance, On October 2023, GenDx (U.S.) introduced NGS-Turbo, a next-generation solution designed to transform high-resolution HLA typing. The launch leverages Oxford Nanopore Technologies' sequencing platforms to deliver rapid, accurate, and scalable typing results, significantly improving turnaround time and enhancing compatibility assessment in transplant diagnostics. The adoption of Next-Generation Sequencing (NGS) for HLA typing is critical as it offers unparalleled resolution at the allele level, leading to more accurate donor-recipient matching and significantly reducing the risk of graft-versus-host disease (GVHD) and rejection. Furthermore, the development of non-invasive monitoring using molecular assays, such as quantifying dd-cfDNA in the recipient's blood, provides an early, reliable biomarker for allograft injury, moving clinical management towards personalized medicine strategies. This trend is accelerated by increasing R&D funding and favorable regulatory approvals for these cutting-edge tests.

Transplant Diagnostics Market- Segmentation Analysis:

The Global Transplant Diagnostics Market is segmented on the basis of Product Type, Technology, Application, End-user, and Region.

The market is divided into three categories based on Product Type: Reagents & Consumables, Instruments, and Software & Services. The Reagents & Consumables segment holds the largest share due to the high volume of transplant procedures and the recurring need for specialized HLA typing kits, detection antibodies, and nucleic acid extraction reagents.

The market is divided into two major categories based on Technology: Molecular Assays and Non-Molecular Assays and others. Molecular Assays, encompassing PCR-based and Sequencing-based (NGS, Sanger) methods, dominate the market due to their superior accuracy and high throughput capability essential for resolving complex HLA alleles. Non-Molecular Assays include Serology and Mixed Lymphocyte Culture (MLC) tests.

The market is divided into two categories based on Application: Diagnostic Applications (Pre-transplant Diagnostics, Post-transplant Monitoring) , Research Applications and others. Diagnostic applications are the dominant segment, driven by mandatory pre-transplant compatibility testing.

The market is divided into three categories based on End-user: Hospitals & Transplant Centers, Diagnostic Laboratories, and Research & Academic Institutes and others. Diagnostic Laboratories, including independent reference labs, hold a substantial share due to their high-volume processing capabilities and specialized expertise in complex molecular assays.

Transplant Diagnostics Market- Geographical Insights

North America commands the largest market share, attributable to its sophisticated healthcare infrastructure, high awareness of advanced diagnostic technologies, and a large number of transplant procedures, especially kidney and heart transplants. Europe follows closely, driven by standardized organ sharing programs (like Eurotransplant) and robust public funding for healthcare research, promoting early adoption of non-invasive monitoring systems. The Asia Pacific (APAC) region is projected to be the fastest-growing market, fuelled by rapid improvements in healthcare spending, an increasing incidence of chronic diseases, and evolving government policies that support organ donation programs, particularly in countries like China and India. LATAM and MEA regions exhibit slower, steady growth, primarily constrained by fragmented healthcare systems and high technology costs, though strategic governmental investments are beginning to create market opportunities.

Transplant Diagnostics Market- Country Insights

China is poised to be a high-potential market due to its sheer population size and the significant recent regulatory advancements in its organ donation system. The country has substantially increased its voluntary deceased donor program, leading to a rise in transplant volumes and a corresponding spike in the demand for accurate transplant diagnostics. Key drivers include government initiatives to modernize hospital infrastructure, massive investments in domestic molecular diagnostics R&D, and the increasing adoption of automated, high-throughput HLA typing systems, often locally manufactured or adapted. However, the market faces challenges related to standardizing testing protocols across diverse regional hospitals and addressing the shortage of highly specialized personnel required to interpret complex NGS data. Market entry strategies often involve local partnerships to navigate regulatory frameworks.

Transplant Diagnostics Market- Competitive Landscape:

The global transplant diagnostics market is highly competitive and moderately consolidated, dominated by key players such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., CareDx, Inc., Immucor, Inc. (part of Werfen), Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Abbott Laboratories, Omixon Ltd., and Eurofins Scientific SE. These companies focus heavily on molecular assay platforms, where competition centers around the resolution and speed of HLA typing, sensitivity of antibody detection, and the development of non-invasive graft rejection monitoring tools like dd-cfDNA. Key strategies include Mergers & Acquisitions (M&A) to acquire novel technologies, notably the integration of bioinformatics software for enhanced data interpretation. Companies are aggressively pursuing strategic collaborations with major transplant centers and reference laboratories to expand their product penetration and establish clinical validation for new assays. A prominent trend is the shift towards integrated solutions that combine instruments, reagents, and analytical software into a single, seamless workflow for improved lab efficiency. For example, in October 2025, a leading diagnostics firm acquired a specialized AI-driven platform provider to enhance predictive modeling for post-transplant infection risk.

Recent Developments:

On February 2025, Pirche AG (Germany) entered into a strategic partnership with Devyser AB (Sweden) to advance next-generation transplant diagnostics. The collaboration focuses on integrating Pirche's AI-driven TxPredictor Platform-designed for immune profiling and risk prediction-with Devyser's portfolio of novel biomarkers to enable more personalized monitoring in transplant patients. This combined approach aims to enhance clinical decision-making by improving compatibility assessment, early rejection detection, and overall transplant outcomes.

On May 2024, Thermo Fisher Scientific launched a CXCL10 testing service developed for kidney transplant patients. This advanced assay enables rapid detection of the CXCL10 chemokine, offering faster results compared to currently used diagnostic methods. By improving early identification of inflammatory activity and potential rejection, the service enhances clinical decision-making and supports more effective post-transplant monitoring.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSPLANT DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • Immucor, Inc. (part of Werfen)
  • Illumina, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Omixon Ltd.
  • Eurofins Scientific SE
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Reagents & Consumables
  • Instruments
  • Software & Services
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Molecular Assays
  • PCR-based Assays
  • Sequencing-based Assays (NGS, Sanger)
  • Non-Molecular Assays
  • Serological Assays
  • Mixed Lymphocyte Culture (MLC)
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Applications
  • Pre-transplant Diagnostics (HLA Typing, Cross-matching)
  • Post-transplant Monitoring (Rejection/Infection)
  • Research Applications
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Transplant Centers
  • Diagnostic Laboratories (Independent Reference Labs)
  • Research & Academic Institutes
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Transplant Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Transplant Diagnostics Market Snippet by Product Type
    • 2.1.2. Transplant Diagnostics Market Snippet by Technology
    • 2.1.3. Transplant Diagnostics Market Snippet by Application
    • 2.1.4. Transplant Diagnostics Market Snippet by End-user
    • 2.1.5. Transplant Diagnostics Market Snippet by Country
    • 2.1.6. Transplant Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Transplant Diagnostics Key Market Trends

  • 3.1. Transplant Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Transplant Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Transplant Diagnostics Market Opportunities
  • 3.4. Transplant Diagnostics Market Future Trends

4. Transplant Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Transplant Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Transplant Diagnostics Market Landscape

  • 6.1. Transplant Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Transplant Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Instruments
    • 7.1.4. Software & Services
    • 7.1.5. Others

8. Transplant Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 8.1.2. Molecular Assays
      • 8.1.2.1. PCR-based Assays
      • 8.1.2.2. Sequencing-based Assays (NGS, Sanger)
    • 8.1.3. Non-Molecular Assays
      • 8.1.3.1. Serological Assays
      • 8.1.3.2. Mixed Lymphocyte Culture (MLC)
    • 8.1.4. Others

9. Transplant Diagnostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 9.1.2. Diagnostic Applications
      • 9.1.2.1. Pre-transplant Diagnostics (HLA Typing, Cross-matching)
      • 9.1.2.2. Post-transplant Monitoring (Rejection/Infection)
    • 9.1.3. Research Applications
    • 9.1.4. Others

10. Transplant Diagnostics Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 10.1.2. Hospitals & Transplant Centers
    • 10.1.3. Diagnostic Laboratories (Independent Reference Labs)
    • 10.1.4. Research & Academic Institutes
    • 10.1.5. Others

11. Transplant Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Transplant Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Transplant DiagnosticsKey Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.13.6. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Transplant DiagnosticsKey Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.15.3. PhilippinesMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Transplant Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Transplant DiagnosticsKey Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.9. UAE
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.9.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.9.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.9.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.9.6. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)

12. Key Vendor Analysis- Transplant Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. Bio-Rad Laboratories, Inc.
    • 12.2.3. CareDx, Inc.
    • 12.2.4. Immucor, Inc. (part of Werfen)
    • 12.2.5. Illumina, Inc.
    • 12.2.6. Qiagen N.V.
    • 12.2.7. F. Hoffmann-La Roche AG
    • 12.2.8. Abbott Laboratories
    • 12.2.9. Omixon Ltd.
    • 12.2.10. Eurofins Scientific SE
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us